Investors

Investor News

2024

17.09.2024

High interest in Exentis at IMTS 2024 in Chicago

First-time participation in “International Manufacturing Technology Show” in Chicago exceeds expectations
Visitors impressed by unique advantages of Exentis’ 3D technology platform
Numerous orders for production systems and contract manufacturing expected in the US by year-end

03.09.2024

Profitable growth continued in the first half of 2024

Group revenues increased by 24 % to CHF 14.1 million
EBITDA margin improved to 23 %
Promising development of new core market USA

21.06.2024

Exentis Group AG Annual General Meeting 2024

Annual General Meeting well attended by 120 shareholders
Shareholders approve Board proposals with a large majority of votes
Board strengthened by two experts

27.05.2024

Exentis reports revenue and earnings growth in the financial year 2023

18 Exentis 3D systems sold
Exentis strengthens Board of Directors
Outlook 2024: approx. CHF 50 million revenues

17.04.2024

Successful first-time participation of Exentis in ceramitec trade fair in Munich

High interest in Exentis 3D technology platform for large-scale manufacturing of ceramic parts
Exentis with convincing solutions within this year’s trade fair focus on sustainability, energy efficiency, and automation
Visitors impressed by precision and surface quality of parts produced with Exentis’ technology

22.03.2024

Exentis Pharma production system of the latest generation delivered

Production capacity of up to 10 million tablets per year
Freely adjustable release profile of active pharmaceutical ingredients in the human body thanks to tablet geometry
Exentis as technology pioneer in the production of 3D-printed tablets

20.03.2024

Successful participation of Exentis in AMUG in Chicago, Illinois

First-time participation in “Additive Manufacturing Users Group Conference” (AMUG) in Chicago exceeds all expectations
High level of interest in Exentis 3D technology platform
Large number of new customer orders

15.02.2024

Exentis business update

Solid business recorded towards year-end 2023
US activities already underway with several customers
Revenue target of approx. CHF 50 million for the financial year 2024

2023

18.10.2023

High interest in Exentis at Commerzbank’s Pre-IPO Summit 2023

Strong interest in Exentis at conference of IPO candidates
Meetings with 16 renowned institutional investors and family offices
Positive feedback on technology expertise, strategic initiatives and license-based business model

02.10.2023

Exentis accelerates market penetration by splitting the business development function

Optimized market development going forward via the two Management Board functions Chief Commercial Officer and Chief Product Officer
Michael Leitner takes over the sales function, Dr Srdan Vasic the product function
Implementation of Additive-Manufacturing-as-a-Service (AMaaS)

31.08.2023

High attention for Exentis at Formnext Forum Austin

Great interest in Exentis at Formnext Forum Austin, Texas
High demand for ultra-fine structured applications manufactured on Exentis’ Additive Technology Platform
Following the establishment of Exentis North America Inc., Exentis will consistently grow its footprint in the USA

24.08.2023

Profitable growth course continued in the first half of 2023

Group revenues increased by 15% to CHF 11.4 million, EBITDA margin improved to 18.7%
Three strategic initiatives being implemented to realize the market potential
Positive outlook for the full year 2023

23.06.2023

Exentis Group AG Annual General Meeting 2023

Shareholders approve the proposals of the Board with a large majority
Current Board confirmed, Albert F. Angehrn elected as new member
Articles of Incorporation adapted to new stock corporation law

05.06.2023

Successful financial year 2022 for Exentis

14 Exentis 3D systems sold – triple compared to 2021
Solid operating performance in financial year 2022 – run rate CHF 26.0 million
Positive EBITDA before extraordinary one-off effects

10.05.2023

Exentis appoints Eric Bert as President Exentis Americas

Exentis accelerates internationalization by expanding into the USA
Establishment of sales and service network via newly formed entity Exentis North America, Inc.
Exentis attracted Eric Bert, an experienced executive

03.05.2023

Successful trade fair presence of Exentis

Participation in German Hannover Messe trade fair exceeds all expectations
High interest in Exentis 3D technology platform
Strategic business area New Energy in the focus

24.03.2023

Exentis’ licensee Laxxon Medical enters into a cooperation with Hovione for the industrial manufacturing of 3D printed tablets

Conclusion of a long-term strategic cooperation agreement between Laxxon Medical and Hovione, a leading manufacturer in the pharmaceutical industry
Accelerated establishment of the Exentis clean room 3D technology platform within the pharmaceutical industry
Large-scale production of innovative 3D printed tablets with a freely adjustable release profile for the active pharmaceutical ingredients

22.02.2023

Third 3D production system delivered to Ohnhäuser

Contract manufacturing capacity for Exentis customers significantly increased to 10 million parts
Production and development cooperation with Ohnhäuser further extended
Exentis 3D production system delivered within six weeks

17.01.2023

Ohnhäuser acquires third Exentis 3D production system

Ohnhäuser being the exclusive contract manufacturer for Exentis since 2019
Significant expansion of contract manufacturing capacity for Exentis customers
Series production capacity increased to more than 10 million parts per year

2022

20.12.2022

PHENOGY acquires first Exentis 3D system

PHENOGY acquires first Exentis 3D system in addition to exclusive production license
Exentis 3D technology platform to be used for large-scale production of sustainable energy storage systems
Delivery of the 3D system to PHENOGY still in 2022

16.12.2022

Successful start up of the first Exentis 3D system in Japan

Delivery and start-up of the first Exentis 3D system in Japan successfully completed
Exentis showroom at Sintokogio opened
Already several projects with Japanese customers initiated by Sintokogio

08.12.2022

3D community member Whitecell Power receives 3D production system

Exentis delivers another 3D system
Intended use is final development of innovative bipolar plates for fuel cells
Whitecell Power secures option to purchase a second 3D system

24.11.2022

New Exentis website for further growth and internationalization of the Group

Target group-oriented communication for further internationalization of the Group
Early information and enthusiasm for Exentis’ Industrialized Additive Manufacturing
First element of comprehensive realignment of the marketing strategy

28.09.2022

Exentis’ 3D Community member Whitecell Power presents first own fuel cell powered van

Exclusive Whitecell Power customer event at the Exentis 3D Innovation Center
Whitecell Power presents first own fuel cell powered van “Whitecell Power e-Crafter”
Exentis manufactures next generation of bipolar plates for Whitecell Power’s fuel cells

15.09.2022

High attention for Exentis’ 3D technology in Japan

Exentis on the front page of the Nikkan Kogyo Shimbun
Great interest in Exentis’ Industrialized Additive Manufacturing
Positive momentum for further expansion of the Exentis 3D Community in Japan expected

30.08.2022

Most successful first half year in corporate history

Turnover revenue of CHF 10 million generated
7 systems already sold in the first half, compared to 5 systems in the entire financial year 2021
Additional “contracted business” (in CHF million) in the mid single digit range

06.07.2022

Major order for production of pharmaceutical cleanroom 3D systems

Laxxon Medical orders three Exentis 3D production systems
Expansion of 3D tablet production in the USA and Europe
Delivery to begin in current year

30.06.2022

Exentis Group AG – Annual General Meeting 2022

Shareholders approve all proposals of the Board of Directors
Discharge of the Board of Directors
Creation of new authorized capital

24.06.2022

Expansion of internationalisation strategy – Conclusion of distribution partnership in Japan

With Sintokogio Ltd., Exentis gains experienced technology distributor in Japan
Opening of Japanese showroom in preparation
First Exentis 3D system placed in Japan

25.05.2022

Successful Rapid.Tech 3D trade fair for Exentis

High interest in Exentis technology platform
Particular demand in the core segment “New Energy”
Sustainability aspects of the technology increasingly important

18.05.2022

2021 most successful business year of Exentis

Sales CHF 20 million, EBITDA CHF 3.5 million
First Exentis 3D system placed in the USA
Presentation of annual report on June 08, 2022

15.03.2022

Value chain completed

Core functions expanded with more than 50 new employees
Engineering, steering IT as well as final assembly significantly strengthened
Accelerated realisation of 3D systems

09.03.2022

Capital increase successfully completed

Capital increase of CHF 15 million successfully completed
Potential for growth investments created
Fiscal year 2021 the most successful in the company’s history

2021

01.12.2021

Successful trade fair presence of Exentis Group

Strong response to trade fair presence at productronica in Munich
Various application possibilities in the field of electronics

04.11.2021

Exentis Group and Fraunhofer IFAM amplify co-operation

Fraunhofer IFAM Dresden launches new Exentis 3D development system for 3D screen printing
Connecting application development and industrialized 3D production

24.09.2021

Exentis Group successfully represented at two trade fairs

In Lucerne at the Additive Manufacturing Expo (AM Expo)
In Munich at the ceramitec conference
Great demand for the Exentis 3D technology platform, the only Industrialized Additive Manufacturing

04.08.2021

Profitable growth in the first half of 2021

Shipping of numerous Exentis 3D systems and concluding further licensing agreements
Revenue of CHF 9.55 million and earnings before interest and taxes (EBIT) of CHF 2.39 million generated
Full-year outlook: Continued double-digit profitable growth

25.06.2021

Exentis Group AG – Annual General Meeting 2021

Shareholders approve all proposals of the Board of Directors
Discharge and re-election of the Board of Directors
Election of BDO as auditors for the financial year 2021

02.06.2021

Exentis Group AG – Profitable growth

Obtaining of new development projects, licenses, and orders
Revenue of the first five months of 2021 higher than total revenue of the most successful year to date

01.06.2021

Exentis Group AG – Successful internationalisation

Delivery of the first three out of four Exentis 3D systems to Australia
Production of pharmaceutical products and industrial applications
Expansion embedded in licensing agreements

27.04.2021

Exentis Group AG – Successful ISO 9001 certification

Exentis successfully ISO 9001 certified
Underlines commitment to meet international standards
Standardised processes support further growth

15.02.2021

Exentis Group AG – Recent developments 2021

Beginning of 2021 with high demand for Exentis 3D production systems and large-scale production
Financial year 2020 affected by Corona influences
From today’s perspective, 2021 will be the most successful financial year ever in the company’s history

10.02.2021

Exentis strengthens management with the appointment of Gereon Heinemann as CEO/COO

Extensive international board experience in building and leading technology companies
Many years of market experience in establishing successful 3D business models
Joint responsibility for the Chief Executive Officer and Chief Operating Officer departments

Contact us

Benjamin del Fabro
Head of Investor Relations

+41 44 520 46 00
investor@exentis-group.com